EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

β‐Sitosterol as an Anti‐Tumour Active Component of Herba Sarcandrae Inhibits Colorectal Cancer Progression Through Up‐Regulation of TBX20

Haixiao Yuan, Weiqing Feng, Shaohua Yang, Hao Yin, Shaoyong Ouyang, Hong Xie, Hongmei Tang, Xiaowei Ou, Xianling Gong, Jie Yuan iD

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70809 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Haixiao Yuan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Director's Office, Guancun Health Center, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Sitosterols, T-Box Domain Proteins, Up-Regulation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Special Project for Clinical and Basic Sci&Tech Innovation of Guangdong Medical University, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a common malignant tumor of the digestive tract with a high incidence rate. Herba Sarcandrae (HS) is an antipyretic and has been reported to have anti‐cancer effects. This study explored the impacts of β‐sitosterol on the sensitivity of CRC to 5‐fluorouracil (5‐FU) and oxaliplatin and the stability of TBX20 protein in CRC cells. There were 41 HS active ingredients and 265 corresponding potential targets, and 48 potential targets of HS were enriched in CRC. Then, 206 differentially expressed genes (DEGs) related to TBX20 overexpression were screened based on the TCGA database, some of which were associated with TMN stages of COAD patients. Epimedin C, rutin, and β‐sitosterol, which could be combined with TBX20, were screened and validated in CRC cells. Functionally, β‐sitosterol could suppress proliferation and induce apoptosis of CRC cells. β‐sitosterol could also enhance the sensitivity of CRC to 5‐FU and oxaliplatin. In xenograft models, both HS and β‐sitosterol treatments inhibited tumor growth and upregulated TBX20 protein expression, with β‐sitosterol demonstrating a stronger effect. Mechanistically, β‐sitosterol may stabilize TBX20 by inhibiting its ubiquitin‐mediated degradation. In conclusion, β‐sitosterol, as an anti‐tumor active component of HS, prevents CRC cell proliferation, and accelerates apoptosis by upregulating TBX20.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsSitosterolsT-Box Domain ProteinsUp-RegulationHumansAnimalsCell ProliferationGene Expression Regulation, NeoplasticFluorouracilApoptosisCell Line, TumorXenograft Model Antitumor AssaysMiceDisease ProgressionMice, NudeOxaliplatinMice, Inbred BALB CFemaleMale

Stichwörter der Autor:innen

Herba SarcandraeTBX20colorectal cancernetwork pharmacologyβ‐Sitosterol

Substanzen

gamma-sitosterolSitosterolsT-Box Domain ProteinsFluorouracilOxaliplatin

Autor:innen und Institutionen

  • Director's Office, Guancun Health Center, Guangzhou, Guangdong, China.
  • Foshan Clinical Medical School, Guangzhou University of Chinese Medicine, Foshan, Guangdong, China.
  • Department of General Surgery, Foshan Fosun Chancheng Hospital, Foshan, Guangdong, China.
  • Pharmaceutical Department, First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • School of Pharmacy, Guangdong Medical University, Dongguan, Guangdong, China.
  • The Affiliated Fosun Chancheng Hospital, Guangdong Medical University (Foshan Fosun Chancheng Hospital), Foshan, Guangdong, China.

ORCID-Profile: Jie Yuan

Förderung

  • Guangdong Basic and Applied Basic Research Foundation
  • Special Project for Clinical and Basic Sci&Tech Innovation of Guangdong Medical University
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Yuan, H., Feng, W., Yang, S., Yin, H., Ouyang, S., Xie, H., Tang, H., Ou, X., Gong, X., & Yuan, J. (2025). β‐Sitosterol as an Anti‐Tumour Active Component of Herba Sarcandrae Inhibits Colorectal Cancer Progression Through Up‐Regulation of TBX20. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70809

Vancouver

Yuan H, Feng W, Yang S, Yin H, Ouyang S, Xie H, et al. β‐Sitosterol as an Anti‐Tumour Active Component of Herba Sarcandrae Inhibits Colorectal Cancer Progression Through Up‐Regulation of TBX20. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70809

BibTeX
@article{Yuan2025,
  author = {Yuan, Haixiao and Feng, Weiqing and Yang, Shaohua and Yin, Hao and Ouyang, Shaoyong and Xie, Hong and Tang, Hongmei and Ou, Xiaowei and Gong, Xianling and Yuan, Jie},
  title = {β‐Sitosterol as an Anti‐Tumour Active Component of Herba Sarcandrae Inhibits Colorectal Cancer Progression Through Up‐Regulation of TBX20},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70809}
}
Kostenlos starten →